A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B
Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy
Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States
A short course of pegylated interferon-α in acute HCV hepatitis
Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters
Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma
Swine-like hepatitis E viruses are a cause of unexplained hepatitis in the Netherlands